Treatment of recurrent respiratory tract infections with a polyvalent bacterial lysate: Results of an open, prospective, multinational study

Advances in Therapy

Volumn 17, Issue 2, 2000, Pages 103-116

  Grevers, Gerd ^a,e   Palacios, Oscar Aldrey ^b   Rodriguez, Bertha ^c   Abel, Stephan ^d   Van Aubel, Antje ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Mexicana Air Lines   (Mexico)

^d Sankyo Pharma GmbH   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial lysate; Large scale study; Oral immunostimulation; Recurrent respiratory tract infections; Safety study

Indexed keywords

BACTERIUM LYSATE; IMMUNOMODULATING AGENT; LW 50020;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIA; CENTRAL AMERICA; CHILD; CLINICAL TRIAL; DRUG SAFETY; EUROPE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SKIN MANIFESTATION; SOUTH AMERICA;

EID: 0033919524     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02854843     Document Type: Article

References (31)

1. Shapiro ED. Epidemiology of acute respiratory infections. Semin Pediatr Infect Dis. 1998;9:31-36.
2. Ramos EG, Suarez EP, Sapian LA, De la Fuente GL. Estudio epidemiológico y etiolögico de las infecciones respiratorias agudas (IRA) en ninos menores de cinco anos. Rev Latinoam Microbiol. 1991;33:109-119.
3. Åberg N, Sundell J, Eriksson B, Hesselmar B, Åberg B. Prevalence of allergic diseases in school-children in relation to family history, upper respiratory infections, and residential characteristics. Allergy. 1996;51:232-237.
4. Rodriguez AF, Mejia CR, Prado D, Arguedas A. Infectious diseases in Central America: the current situation. Infect Med. 1996;208:212-215.
5. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infekt. 1993;110:145-160.
6. van Cauwenberge P, Ingels K. Effects of viral and bacterial infection on nasal and sinus mucosa. Acta Otolaryngol 1996;116:316-321.
7. Söderström M, Hovelius B, Prellner K. Respiratory tract infections in children with recurrent episodes as preschoolers. Acta Pædiatr Scand. 1991;80:688-695.
8. Busse WW. The role of respiratory infections in airway hyperresponsiveness and asthma. Am J Respir Crit Care Med. 1994;150:77-79.
9. Newman-Taylor A. Environmental determinants of asthma. Lancet, 1995;345:296-299.
10. Cazzola M, Matera MG, Rossi F. Bronchial hyperresponsiveness and bacterial respiratory infections. Clin Ther. 1991;13:157-171.
11. Clancy R, Pang G, Dunkley M, Taylor D, Cripps A. Acute or chronic bronchitis: a model of mucosal immunology. Immunol Cell Biol. 1995;73:414-417.
12. Taylor DC, Clancy RL, Cripps AW, Butt H, Bartlett L, Murree-Allen K. An alteration in the host-parasite relationship in subjects with chronic bronchitis prone to recurrent episodes of acute bronchitis. Immunol Cell Biol. 1994;72:143-151.
13. Paoletti P, Prediletto R, Carrozzi L, et al. Effects of childhood and adolescence-adulthood respiratory infections in a general population. Eur Respir J. 1989;2:248-436.
14. O'Hagan DT. Oral delivery of vaccines: formulation and clinical pharmacokinetic considerations. Clin Pharmacokinet. 1992;22:1-10.
15. Helmberg A, Bock G, Wolf H, Wick G. An orally administered bacterial immunomodulator primes rabbit neutrophils for increased oxidative burst in response to opsonized zymosan. Infect Immun. 1989;57:3576-3580.
16. van Daal GJ, Beusenberg FD, So KL, et al. Protection against influenza virus infection in mice by oral immunization with a polyvalent bacterial lysate. Int J Immunopharmacol. 1991;13:831-840.
17. van Daal GJ, van't Veen A, So KL, et al. Oral immunization with polyvalent bacterial lysate and infection with Streptococcus pneumoniae: influence on interferon-gamma and PMN-elastase concentrations in murine bronchoalveolar lavage fluid. Int Arch Allergy Immunol. 1992;97:173-177.
18. Ruedl CH, Albin B, Böck G, Wick G, Wolf H. Oral administration of a bacterial immunomodulator enhances murine intestinal lamina propria and Peyer's patch lymphocyte traffic to the lung: possible implications for infectious disease prophylaxis and therapy. Int Immunol. 1993;5:29-36.
19. Ruedl CH, Frühwirth M, Wick G, Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin Diagn Lab Immunol. 1994;1:150-154.
20. Riedl-Seifert RJ, van Aubel A, Kämmereit A, Elsasser U. Recurrent infections during childhood - are they still a "crux medicorum"? Results of a placebo-controlled double-blind study with an oral bacterial lysate in children prone to infections. J Pharmacol Ther. 1993;3:108-117.
21. Ruah SB, Abel S, Binder M, van Aubel A, Elsasser U, Kämmereit A. Paspat Oral in Portugal -Prevention and Therapy of Respiratory Tract Infections in Infection-Prone Children. A Double-Blind, Placebo-Controlled, Multicenter Study, Study No. FK-09/92. Research Report. Munich, Germany: Luitpold Pharma; 1996.
22. Rutishauser M, Pitzke P, Grevers G, van Aubel A, Elsasser U, Kämmereit A. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study. Adv Ther. 1998;15:330-341.
23. van Aubel A, Kämmereit A. Therapy of recurrent respiratory tract infections with the 'vaccinoid' Luivac. In: Mucosal Immunology. Munich: W Zuckschwerdt Verlag; 1998:109-118.
24. Alho OP, Koivu M, Sorri M, Rantakallio P. Risk factors for recurrent acute otitis media and respiratory tract infection in infancy. Int J Pediat Otorhinolaryngol. 1990;19:151-161.
25. Tainio VM, Savilahti E, Salmemperä L, Arjomaa P, Siimes MA, Perheentupa J. Risk factors for infantile recurrent otitis media: atopy but not type of feeding. Pediatr Res. 1988;23:509-512.
26. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy. 1998;28:3-10.
27. Strachan DP, Butland BK, Anderson HR. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ. 1996;312:1195-1199.
28. Kilian K, Husby S, Host A, Halken S. Increased proportions of bacteria capable of cleaving IgA1 in the pharynx of infants with atopic disease. Pediatr Res. 1995;38:182-186.
29. Caers G. Infections récidivants des voies respiratoires supérieurs: leur traitement médical. Acta Otorhinolaryngol Belg. 1993;47:221-229.
30. Cazzola M, Ariano R, Gioia V, et al. Bacterial isolates and cigarette smoking in patients with chronic bronchitis: results from an Italian multicenter survey. Clin Ther. 1990;12:105-117.
31. Büchner KR. Treatment of Out-patients With Recurrent Respiratory Tract Infections. Basel, Switzerland: Infratest Suisse; 1993.